OLIGONUCLEOTIDES FOR MEDICAL APPLICATIONS
The multipartner, multidisciplinary project OLIGOMED addresses urgent needs in healthcare, in particular cancer, Huntington's Disease and cardiovascular diseases.
We apply cutting edge oligonucleotide technology to find innovative solutions and create a novel platform for personalised medicine.
Click below to learn more about our rationale behind the project, to meet the team, to learn more about the consortium, and to keep up to date with us.
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska Curie grant agreement No 956070.
EU H2020 MSC ETN - Project 956070 OLIGOMED